+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Continuous Subcutaneous Insulin Infusion Market - Global Forecast 2026-2032- Product Image
Continuous Subcutaneous Insulin Infusion Market - Global Forecast 2026-2032- Product Image
New

Continuous Subcutaneous Insulin Infusion Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 181 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 5337448
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The continuous subcutaneous insulin infusion market is advancing rapidly, driven by device innovation, integration with digital health, and shifting care pathways. Senior decision-makers face evolving challenges and opportunities as CSII solutions shift the paradigm of chronic diabetes care, compelling new approaches for clinical outcomes and operational value.

Market Snapshot: Continuous Subcutaneous Insulin Infusion Market Outlook

The continuous subcutaneous insulin infusion market grew from USD 3.41 billion in 2025 to USD 3.81 billion in 2026. It is projected to maintain strong momentum, expanding at a CAGR of 12.62% and reaching USD 7.84 billion by 2032. Significant drivers include the convergence of closed-loop therapy, digital integration, and enhanced payer scrutiny, positioning CSII as a cornerstone of modern diabetes management.

Scope & Segmentation: Strategic Depth Across Devices, Users, and Geographies

  • Device Types: Conventional pumps (including electronics-based and mechanical variants), and patch pumps with diverse programming capabilities and form factors.
  • Insulin Formulations: Coverage of rapid-acting analogs, regular insulins, and short-acting solutions to meet a range of pharmacokinetic and daily lifestyle requirements.
  • Age Cohort: Detailed analysis of adoption across adults, geriatric populations, and pediatric patients, focusing on user experience, cognitive load, and support needs.
  • End User/Care Setting: Examination of usage in ambulatory, homecare, and hospital environments with assessment of device robustness, interoperability, and clinical oversight priorities.
  • Regional Coverage: Comprehensive review encompasses the Americas, Europe, Middle East & Africa, and Asia-Pacific, considering regulatory, reimbursement, and delivery system differences.
  • Technology Integration: Insights into closed-loop systems, sensor integration, data-enabled care, and cloud-based platforms for improved management and monitoring.

Key Takeaways for Decision-Makers

  • CSII adoption is catalyzed by digital innovation, streamlined workflows, and enhanced remote care capabilities across clinical settings.
  • Strategic segmentation by device type, insulin formulation, age cohort, and care context helps optimize product fit, training, and evidence generation.
  • Manufacturers are investing in lifecycle management, interoperability, and post-market support services to drive differentiation and align with payer value narratives.
  • Regional strategies must account for local care models, varying regulatory pathways, and reimbursement structures to ensure optimal market access and sustained adoption.
  • Stakeholder engagement—particularly with payers and clinicians—is crucial for validating outcomes, reducing training burden, and informing future device design.

Tariff Impact: Navigating Trade Policy for Supply Chain Resilience

The implementation of revised tariff regimes in 2025, notably in the United States, created new complexities for CSII suppliers and buyers. These policy shifts prompted manufacturers to accelerate supply chain localization, optimize sourcing strategies, and adopt tariff mitigation measures. Procurement practices have responded through renegotiated contracts, adjusted inventory policies, and investment in redundancy. Strategic planning around tariff risk remains essential for price stability and uninterrupted market supply.

Methodology & Data Sources

This report synthesizes primary qualitative interviews with clinicians, procurement experts, payers, and device engineers, combined with regulatory reviews, secondary literature, real-world evidence, and vendor assessments. Scenario-based workshops explored supply chain resilience and tariff responses. A focus on triangulating multiple data sources ensures a robust and actionable foundation for senior decision-making.

Why This Report Matters

  • Enables actionable planning by unpacking the latest multidimensional trends in technology, supply chain, and market access.
  • Supports investment and procurement strategies with granular segmentation and regional analysis, strengthening competitive positioning.
  • Guides evidence-based decision-making through transparency about research assumptions and real-world experience.

Conclusion

The evolution of continuous subcutaneous insulin infusion solutions depends on integrated device, data, and evidence strategies. Senior decision-makers leveraging these insights will be better positioned to enhance diabetes care while navigating operational, regional, and technological demands.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Continuous Subcutaneous Insulin Infusion Market, by Product Type
8.1. Conventional
8.1.1. Electronics Based Pumps
8.1.2. Mechanical Pumps
8.2. Patch
9. Continuous Subcutaneous Insulin Infusion Market, by Insulin Type
9.1. Rapid Acting Analog
9.2. Regular Insulin
9.3. Short Acting
10. Continuous Subcutaneous Insulin Infusion Market, by Age Group
10.1. Adult
10.2. Geriatric
10.3. Pediatric
11. Continuous Subcutaneous Insulin Infusion Market, by End User
11.1. Ambulatory Care
11.2. Homecare
11.3. Hospitals
12. Continuous Subcutaneous Insulin Infusion Market, by Region
12.1. Americas
12.1.1. North America
12.1.2. Latin America
12.2. Europe, Middle East & Africa
12.2.1. Europe
12.2.2. Middle East
12.2.3. Africa
12.3. Asia-Pacific
13. Continuous Subcutaneous Insulin Infusion Market, by Group
13.1. ASEAN
13.2. GCC
13.3. European Union
13.4. BRICS
13.5. G7
13.6. NATO
14. Continuous Subcutaneous Insulin Infusion Market, by Country
14.1. United States
14.2. Canada
14.3. Mexico
14.4. Brazil
14.5. United Kingdom
14.6. Germany
14.7. France
14.8. Russia
14.9. Italy
14.10. Spain
14.11. China
14.12. India
14.13. Japan
14.14. Australia
14.15. South Korea
15. United States Continuous Subcutaneous Insulin Infusion Market
16. China Continuous Subcutaneous Insulin Infusion Market
17. Competitive Landscape
17.1. Market Concentration Analysis, 2025
17.1.1. Concentration Ratio (CR)
17.1.2. Herfindahl Hirschman Index (HHI)
17.2. Recent Developments & Impact Analysis, 2025
17.3. Product Portfolio Analysis, 2025
17.4. Benchmarking Analysis, 2025
17.5. B. Braun SE
17.6. Baxter International, Inc.
17.7. Becton, Dickinson and Company
17.8. Bigfoot Biomedical, Inc.
17.9. BPL Medical Technologies Private Limited
17.10. CeQur SA
17.11. F. Hoffmann-La Roche Ltd.
17.12. Forbion
17.13. Fresenius SE & Co. KGaA
17.14. Insulet Corporation
17.15. MannKind Corporation
17.16. Medtronic PLC
17.17. MicroPort Scientific Corporation
17.18. Nipro Corporation
17.19. Pharmasense AG
17.20. Sanofi S.A.
17.21. Shinmyung Mediyes CO., LTD.
17.22. SOOIL Developments Co., Ltd.
17.23. Tandem Diabetes Care, Inc.
17.24. Terumo Group
17.25. Ypsomed AG
List of Figures
FIGURE 1. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY INSULIN TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY AGE GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. UNITED STATES CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 12. CHINA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY CONVENTIONAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY CONVENTIONAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY CONVENTIONAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY CONVENTIONAL, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY ELECTRONICS BASED PUMPS, BY REGION, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY ELECTRONICS BASED PUMPS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY ELECTRONICS BASED PUMPS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY MECHANICAL PUMPS, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY MECHANICAL PUMPS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY MECHANICAL PUMPS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATCH, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATCH, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATCH, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY INSULIN TYPE, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY RAPID ACTING ANALOG, BY REGION, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY RAPID ACTING ANALOG, BY GROUP, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY RAPID ACTING ANALOG, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY REGULAR INSULIN, BY REGION, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY REGULAR INSULIN, BY GROUP, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY REGULAR INSULIN, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY SHORT ACTING, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY SHORT ACTING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY SHORT ACTING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY ADULT, BY REGION, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY ADULT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY ADULT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY GERIATRIC, BY REGION, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY GERIATRIC, BY GROUP, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY GERIATRIC, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PEDIATRIC, BY GROUP, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PEDIATRIC, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY AMBULATORY CARE, BY REGION, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY AMBULATORY CARE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY AMBULATORY CARE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY HOMECARE, BY REGION, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY HOMECARE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY HOMECARE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 47. AMERICAS CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 48. AMERICAS CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 49. AMERICAS CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY CONVENTIONAL, 2018-2032 (USD MILLION)
TABLE 50. AMERICAS CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY INSULIN TYPE, 2018-2032 (USD MILLION)
TABLE 51. AMERICAS CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 52. AMERICAS CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 53. NORTH AMERICA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 54. NORTH AMERICA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 55. NORTH AMERICA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY CONVENTIONAL, 2018-2032 (USD MILLION)
TABLE 56. NORTH AMERICA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY INSULIN TYPE, 2018-2032 (USD MILLION)
TABLE 57. NORTH AMERICA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 58. NORTH AMERICA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 59. LATIN AMERICA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 60. LATIN AMERICA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 61. LATIN AMERICA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY CONVENTIONAL, 2018-2032 (USD MILLION)
TABLE 62. LATIN AMERICA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY INSULIN TYPE, 2018-2032 (USD MILLION)
TABLE 63. LATIN AMERICA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 64. LATIN AMERICA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 65. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 66. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 67. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY CONVENTIONAL, 2018-2032 (USD MILLION)
TABLE 68. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY INSULIN TYPE, 2018-2032 (USD MILLION)
TABLE 69. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 70. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 71. EUROPE CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 72. EUROPE CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 73. EUROPE CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY CONVENTIONAL, 2018-2032 (USD MILLION)
TABLE 74. EUROPE CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY INSULIN TYPE, 2018-2032 (USD MILLION)
TABLE 75. EUROPE CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 76. EUROPE CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 77. MIDDLE EAST CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 78. MIDDLE EAST CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 79. MIDDLE EAST CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY CONVENTIONAL, 2018-2032 (USD MILLION)
TABLE 80. MIDDLE EAST CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY INSULIN TYPE, 2018-2032 (USD MILLION)
TABLE 81. MIDDLE EAST CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 82. MIDDLE EAST CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 83. AFRICA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 84. AFRICA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 85. AFRICA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY CONVENTIONAL, 2018-2032 (USD MILLION)
TABLE 86. AFRICA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY INSULIN TYPE, 2018-2032 (USD MILLION)
TABLE 87. AFRICA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 88. AFRICA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 89. ASIA-PACIFIC CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 90. ASIA-PACIFIC CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 91. ASIA-PACIFIC CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY CONVENTIONAL, 2018-2032 (USD MILLION)
TABLE 92. ASIA-PACIFIC CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY INSULIN TYPE, 2018-2032 (USD MILLION)
TABLE 93. ASIA-PACIFIC CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 94. ASIA-PACIFIC CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 96. ASEAN CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 97. ASEAN CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 98. ASEAN CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY CONVENTIONAL, 2018-2032 (USD MILLION)
TABLE 99. ASEAN CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY INSULIN TYPE, 2018-2032 (USD MILLION)
TABLE 100. ASEAN CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 101. ASEAN CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 102. GCC CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 103. GCC CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 104. GCC CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY CONVENTIONAL, 2018-2032 (USD MILLION)
TABLE 105. GCC CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY INSULIN TYPE, 2018-2032 (USD MILLION)
TABLE 106. GCC CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 107. GCC CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 108. EUROPEAN UNION CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 109. EUROPEAN UNION CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 110. EUROPEAN UNION CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY CONVENTIONAL, 2018-2032 (USD MILLION)
TABLE 111. EUROPEAN UNION CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY INSULIN TYPE, 2018-2032 (USD MILLION)
TABLE 112. EUROPEAN UNION CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 113. EUROPEAN UNION CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 114. BRICS CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 115. BRICS CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 116. BRICS CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY CONVENTIONAL, 2018-2032 (USD MILLION)
TABLE 117. BRICS CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY INSULIN TYPE, 2018-2032 (USD MILLION)
TABLE 118. BRICS CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 119. BRICS CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 120. G7 CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 121. G7 CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 122. G7 CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY CONVENTIONAL, 2018-2032 (USD MILLION)
TABLE 123. G7 CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY INSULIN TYPE, 2018-2032 (USD MILLION)
TABLE 124. G7 CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 125. G7 CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 126. NATO CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 127. NATO CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 128. NATO CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY CONVENTIONAL, 2018-2032 (USD MILLION)
TABLE 129. NATO CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY INSULIN TYPE, 2018-2032 (USD MILLION)
TABLE 130. NATO CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 131. NATO CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 132. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 133. UNITED STATES CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 134. UNITED STATES CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 135. UNITED STATES CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY CONVENTIONAL, 2018-2032 (USD MILLION)
TABLE 136. UNITED STATES CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY INSULIN TYPE, 2018-2032 (USD MILLION)
TABLE 137. UNITED STATES CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 138. UNITED STATES CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 139. CHINA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 140. CHINA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 141. CHINA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY CONVENTIONAL, 2018-2032 (USD MILLION)
TABLE 142. CHINA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY INSULIN TYPE, 2018-2032 (USD MILLION)
TABLE 143. CHINA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 144. CHINA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this Continuous Subcutaneous Insulin Infusion market report include:
  • B. Braun SE
  • Baxter International, Inc.
  • Becton, Dickinson and Company
  • Bigfoot Biomedical, Inc.
  • BPL Medical Technologies Private Limited
  • CeQur SA
  • F. Hoffmann-La Roche Ltd.
  • Forbion
  • Fresenius SE & Co. KGaA
  • Insulet Corporation
  • MannKind Corporation
  • Medtronic PLC
  • MicroPort Scientific Corporation
  • Nipro Corporation
  • Pharmasense AG
  • Sanofi S.A.
  • Shinmyung Mediyes CO., LTD.
  • SOOIL Developments Co., Ltd.
  • Tandem Diabetes Care, Inc.
  • Terumo Group
  • Ypsomed AG

Table Information

Report AttributeDetails
No. of Pages181
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 3.81 Billion
Forecasted Market Value ( USD ) by 2032 $ 7.84 Billion
Compound Annual Growth Rate12.6%
Regions CoveredGlobal
No. of Companies Mentioned22

Related Topics

Related Reports

Glucose Responsive Insulin System Market - Global Forecast 2025-2032 - Product Image

Glucose Responsive Insulin System Market - Global Forecast 2025-2032

  • Report
  • 188 Pages
  • Global
From
Insulin Patch Pumps Market Report 2025 - Product Image

Insulin Patch Pumps Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Insulin Pumps Market - Global Forecast 2026-2032 - Product Image

Insulin Pumps Market - Global Forecast 2026-2032

  • Report
  • 196 Pages
  • Global
From
Insulin Pumps Market - Focused Insights 2021-2030 - Product Image

Insulin Pumps Market - Focused Insights 2021-2030

  • Report
  • 151 Pages
  • Global
From
Insulin Pumps & Continuous Glucose Monitors Market Size by Segments, Share, Regulatory, Reimbursement and Forecast to 2036 - Product Image

Insulin Pumps & Continuous Glucose Monitors Market Size by Segments, Share, Regulatory, Reimbursement and Forecast to 2036

  • Report
  • 52 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.